Kevin Patrick Lynch
Plus aucun poste en cours
Fortune : - $ au 31/05/2024
Historique de carrière de Kevin Patrick Lynch
Anciens postes connus de Kevin Patrick Lynch
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Directeur/Membre du Conseil | 18/06/2021 | 16/12/2022 |
| Directeur Technique/Scientifique/R&D | 25/03/2021 | 16/12/2022 | |
| CELGENE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Chine | 2 |
| Etats-Unis | 2 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Health Technology |
- Bourse
- Insiders
- Kevin Patrick Lynch
- Expérience
